Expertise in
7
conditions

Suresh Senan

Amsterdam UMC
Amsterdam, NH, NL 
Expertise in
7
conditions
Amsterdam UMC
Amsterdam, NH, NL 

Overview

Suresh Senan practices practicing medicine in Amsterdam, Netherlands.

Mr. Senan is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Cardiac Ablation, and Endoscopy.

He is actively involved in clinical research, co-authoring 278 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Amsterdam UMC
Amsterdam, NH, Netherlands
Other Locations
Noord, NB, Netherlands
Netherlands
Rijnstate Ziekenhuis
Arnhem, GE, Netherlands
Rotterdam, ZH, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as Consolidation Treatment for Patients With Limited Stage Small Cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy (ADRIATIC)
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as Consolidation Treatment for Patients With Limited Stage Small Cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy (ADRIATIC)
Enrollment Status: Active_not_recruiting
Publish Date: November 21, 2025
Intervention Type: Other, Drug
Study Drugs: Durvalumab, Tremelimumab
Study Phase: Phase 3
A Randomized Clinical Trial of Surgery Versus Radiosurgery (Stereotactic Radiotherapy) in Patients With Stage IA NSCLC Who Are Fit to Undergo Primary Resection
A Randomized Clinical Trial of Surgery Versus Radiosurgery (Stereotactic Radiotherapy) in Patients With Stage IA NSCLC Who Are Fit to Undergo Primary Resection
Enrollment Status: Terminated
Publish Date: March 17, 2022
Intervention Type: Procedure, Radiation
Study Phase: Phase 3
View 1 Less Clinical Trial

278 Total Publications

The limits of pooled evidence in early-stage NSCLC: are we comparing treatments or patients?
The limits of pooled evidence in early-stage NSCLC: are we comparing treatments or patients?
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 25, 2026

Frequently Asked Questions about Suresh Senan

Is Suresh Senan a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Suresh Senan is classified as an Elite expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Suresh Senan participate in research or clinical trials?

Yes. Suresh Senan has published 278 articles and abstracts on conditions like Lung Cancer. You can view a list of Suresh Senan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Senan's expertise for a condition
ConditionClose
View All 11 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile